New Personalized Medical Program Enhances Prostate Cancer Diagnosis

New Personalized Medical Program Enhances Prostate Cancer Diagnosis
prostate cancerResearchers from Vienna General Hospital and the Comprehensive Cancer Center at MedUni Vienna reported on a new program based on personalized medicine methods for prostate cancer diagnosis. In Austria, approximately 4,700 men develop prostate cancer every year and during this time frame approximately 1,146 succumb to the disease. The diagnosis of prostate cancer can be made through the analysis of blood for the prostate-specific antigen (PSA); this PSA test, however, is not completely reliable. “Although the PSA is not an ideal marker, it is still the best diagnostic bio-marker across the whole of oncology. At a younger age, i.e., around 40 - 45 years, it is very useful in terms of predicting the risk of prostate cancer. The data also confirms this. Since the PSA screening test was introduced, deaths from prostate cancer have fallen by 40 percent. So the question isn't about whether PSA screening should be carried out or not. It's more about doing it cleverly,” said the study’s lead author Dr. Shahrokh Shariat in a
Subscribe or to access all post and page content.